Oral nutritional supplements for gastric cancer – the review of current evidence
Open Access
- 10 March 2021
- journal article
- review article
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 8 (1), 53-61
- https://doi.org/10.17709/2409-2231-2021-8-1-5
Abstract
The analysis of the current evidence base concerning the use of oral nutritional supplements (ONS) in gastric cancer (GC) has been made. Databases of scientific information eLIBRARY.ru and PubMed were used. Emphasis is placed on randomized clinical trials and meta‑analyses. The application of ONS is suggested for all patients who undergo to surgical treatment for GC. Its use allows increasing protein and energy consumption, improving the quality of life, some parameters of nutritional status and immunity (albumin, blood lymphocytes etc.). In patients with severe malnutrition (SM) ONS can significantly reduce the incidence of clinically important postoperative complications. The use of this type of medical nutrition in the first 5 days after surgery is safe and does not increase the rate of anastomotic leak. After gastrectomy (GE) its administration reduces the time of recovery of bowel motor function and the duration of hospitalization. After distal GE delay of gastric emptying may occur. In patients with SM, early start of enteral nutrition should be considered. After discharge from the hospital ONS can decelerate the progression of malnutrition, improve the tolerance of adjuvant chemotherapy and improve the quality of life. These effects are most clear after GE and in patients with a high risk of malnutrition (NRS‑2002 ≥ 3). There are no evident advantages of any particular type of ONS in patients with GC. When choosing a specific product, preference should be given to formulas with optimal nitrogen: non‑protein kilocalories ratio, osmolarity closest to physiological and individually selected organoleptic properties. It is recommended that the patient consume at least 200–250 ml of the mixture per day, and in the early postoperative period focus have to be made not on the target volume, but on signs of tolerability.Keywords
This publication has 25 references indexed in Scilit:
- Enhanced recovery after surgery (ERAS) versus standard recovery for elective gastric cancer surgery: A meta-analysis of randomized controlled trialsSurgical Oncology, 2019
- THE EFFECT OF NUTRITIONAL THERAPY ON QUALITY OF LIFE INDICATORS FOR PATIENTS WITH GASTRIC CANCER AT THE STAGE OF SURGICAL TREATMENTResearch and Practical Medicine Journal, 2019
- Meta-analysis of preoperative oral nutritional supplements for patients with gastric cancer: East Asian experienceEuropean Journal of Clinical Nutrition, 2019
- Clinical Impact of Sarcopenia on Gastric CancerAnticancer Research, 2019
- Perioperative nutritional support. Russian Federation of anesthesiologists and reanimatologists guidelinesAnnals of Critical Care, 2018
- Effect of perioperative oral nutritional supplementation in malnourished patients who undergo gastrectomy: A prospective randomized trialSurgery, 2018
- Application of enhanced recovery after gastric cancer surgery: An updated meta-analysisWorld Journal of Gastroenterology, 2018
- Prognostic significance of perioperative nutritional parameters in patients with gastric cancerClinical Nutrition, 2018
- ESPEN guideline: Clinical nutrition in surgeryClinical Nutrition, 2017
- The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysisEuropean Journal of Surgical Oncology, 2016